Biotech Medicines - Life science
applied to personalized medicine.

Watch this video. It is pretty interesting - overview of the future of biotech medicines.

More than 250 million people have already benefited from Biotech Medicines and vaccines developed through biotechnology. A survey by the Pharmaceutical Research and Manufacturers of America (PhRMA) a couple years ago - identifies 371 more biotechnology medicines in the pipeline. Nearly 200 diseases are being targeted by this research conducted by 144 companies and the National Cancer Institute.

These new medicines – all of which are in human clinical trials or are awaiting FDA approval –include 178 new medicines for cancer, 47 for infectious diseases, 26 for autoimmune diseases, 22 for neurologic disorders, and 21 for HIV/AIDS and related conditions.

Approved biotech meds already treat or help prevent heart attacks, stroke, multiple sclerosis, leukemia, hepatitis, rheumatoid arthritis, breast cancer, diabetes, congestive heart failure, lymphoma, kidney cancer, cystic fibrosis and other diseases.


Genetic Engineering Research of the 1990s is giving way to biotech medicine during the first two decades of this 21st century.

We have unraveled the human genome and are now isolating specific gene expressions - developing methods to turn on helpful, hindered genes, and also to turn off harmful, defective ones.  

With something as simple as a cotton swab touching the inside of your cheek, you can now have an extensive genetic profile (your genome) report given back to you.  This report will highlight your genetic predispositions to a number of diseases, which you can then use to take corrective action in lifestyle, diet, and exercise decisions. 

We are quickly moving away from generalized medicine to strictly individualized medicine, and genetic testing kits will be one of the primary ways in which this disruptive technology in medicine will be given "mainstream" status. 


The Future of Biotech Medicine

Aubrey de Grey, Ph.D. at Cambridge University - thinks the first therapies for life extension will probably not involve nanotech at all. He thinks the first threapies will be mostly biotech - and we'll get there before nanotech becomes sufficiently sophisticated.



He thinks that it's quite likely that pure biotechnology will come up against some brick walls.  And at that time, we'll need machinery that's fundamentally different from enzymes and vaccines and pharmaceuticals.  As the understanding of biological processes becomes more intricate and more complex, we'll need machinery that we can control as precisely as we control computers. This is the era in which nanomedicine will be at the heart of all medicine.


Welcome to www.BiotechMedicines.com .  If you have an interest in the emerging field of biotechnology as it relates to the application of the life sciences to personalized medicine, please bookmark this important website. 

As new articles and pertinent news and resources becomes available, they will be added to this growing website.  Thanks for stopping by.